Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-04 2:00 pm Purchase | 2024-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | VANGUARD GROUP INC | 2,097,323 5.510% | 2,097,323 (New Position) | Filing History |
| 2024-10-21 4:11 pm Purchase | 2024-09-30 | 13G | TARSUS PHARMACEUTICALS INC TARS | BlackRock, Inc. BLK | 3,755,504 9.900% | 1,240,380 (+49.32%) | Filing History |
| 2024-02-14 4:00 pm Purchase | 2023-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | TANG CAPITAL PARTNERS LP | 2,204,797 6.700% | 203,212 (+10.15%) | Filing History |
| 2024-02-14 3:04 pm Purchase | 2023-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | Cormorant Asset Management, LP | 2,221,422 6.710% | 485,000 (+27.93%) | Filing History |
| 2024-02-14 07:28 am Purchase | 2023-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | RTW Investments, LP | 3,152,341 9.500% | 604,216 (+23.71%) | Filing History |
| 2024-02-13 5:03 pm Sale | 2023-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | Vivo Capital IX, LLC | 894,826 2.700% | -1,367,374 (-60.44%) | Filing History |
| 2024-02-09 10:06 am Purchase | 2023-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | Morgan Stanley MS | 1,943,705 5.900% | 1,943,705 (New Position) | Filing History |
| 2024-02-02 12:40 pm Purchase | 2023-12-29 | 13G | TARSUS PHARMACEUTICALS INC TARS | Cowen Financial Products LLC | 1,911,399 5.770% | 512,416 (+36.63%) | Filing History |
| 2024-02-02 06:05 am Sale | 2023-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | TimesSquare Capital Management LLC | 0 0.000% | -1,429,310 (Position Closed) | Filing History |
| 2024-01-26 11:49 am Purchase | 2023-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | BlackRock, Inc. BLK | 2,515,124 7.600% | 1,188,593 (+89.60%) | Filing History |
| 2024-01-22 5:05 pm Purchase | 2024-01-12 | 13G | TARSUS PHARMACEUTICALS INC TARS | Paradigm BioCapital Advisors LP | 1,927,506 5.800% | 1,927,506 (New Position) | Filing History |
| 2023-05-05 3:28 pm Purchase | 2023-04-28 | 13G | TARSUS PHARMACEUTICALS INC TARS | Cowen Financial Products LLC | 1,398,983 5.220% | 1,398,983 (New Position) | Filing History |
| 2023-02-14 4:00 pm Sale | 2022-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | TANG CAPITAL PARTNERS LP | 2,001,585 7.500% | -90,168 (-4.31%) | Filing History |
| 2023-02-14 3:04 pm Purchase | 2022-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | Cormorant Asset Management, LP | 1,736,422 6.510% | 333,091 (+23.74%) | Filing History |
| 2023-02-14 2:33 pm Unchanged | 2022-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | Perceptive Advisors LLC | 1,296,416 4.900% | 0 (Unchanged) | Filing History |
| 2023-02-14 10:09 am Purchase | 2022-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | RTW Investments, LP | 2,548,125 9.600% | 534,524 (+26.55%) | Filing History |
| 2023-02-13 5:52 pm Sale | 2022-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | Vivo Capital IX, LLC | 2,262,200 8.500% | -725,131 (-24.27%) | Filing History |
| 2023-02-10 10:10 am Unchanged | 2022-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | Flynn James E | 1,324,214 4.960% | 0 (Unchanged) | Filing History |
| 2023-02-09 11:01 am Sale | 2023-01-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | BlackRock, Inc. BLK | 1,326,531 4.900% | -14,728 (-1.10%) | Filing History |
| 2023-02-08 1:16 pm Purchase | 2022-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | BlackRock, Inc. BLK | 1,341,259 5.000% | 1,341,259 (New Position) | Filing History |